响应ROS的Ganoderma lucidum多糖化纳米复合物准前期氧化应激利基,用于结构和功能性糖尿病肌再生
Yucheng Gao1,2,3, Hao Wang1,2,3, Renwang Sheng1,2,3
1Department of Orthopaedics, School of Medicine, Zhongda Hospital, Southeast University, No. 87 Ding Jia Qiao, Nanjing, 210009, Jiangsu, China.
Journal of nanobiotechnology
|February 24, 2026
概括
由于衰老细胞,糖尿病肌损伤会影响愈合. 一种新型的水凝 (GZPT) 含有Ganoderma lucidum多糖可使这些细胞复原,促进糖尿病大鼠的肌修复.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 糖尿病并发症 糖尿病并发症
背景情况:
- 糖尿病患者面临较高的肌损伤率和较差的愈合.
- 肌干细胞/原生细胞 (TSPCs) 功能障碍和衰老影响肌再生.
- 糖尿病TSPCs (dTSPCs) 显示加速衰老和功能受损.
研究的目的:
- 研究dTSPC衰老和受损再生的机制.
- 开发一种用于糖尿病肌愈合的新治疗策略.
- 为了评估Ganoderma lucidum多糖载水凝 (GZPT) 对于糖尿病肌修复的疗效.
主要方法:
- 描述dTSPCs的衰老和功能障碍.
- 开发一种ROS响应的纳米复合物水凝 (GZPT) 封装Ganoderma lucidum多糖体 (GLPs).
- 在体外和体内评估GZPT对dTSPC和糖尿病肌再生的影响.
主要成果:
- dTSPCs表现出由Ras/MAPK轴激活,线粒体功能障碍和ROS产生所驱动的衰老.
- 在实验室中,GZPT有效地抑制了Ca2+流入,抑制了Ras/MAPK激活,减少了ROS,并减弱了dTSPC衰老.
- 通过减轻氧化应激,GZPT在体内促进了糖尿病肌的结构和功能恢复.
结论:
- 通过向Ras/MAPK通路和氧化应激,GZPT可以改善dTSPC衰老和功能障碍.
- 开发的GZPT水凝系统有助于糖尿病人的肌再生.
- 在糖尿病患者中,GZPT显示出作为改善肌修复的临床策略的潜力.
相关概念视频
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

